QIAGEN OmicSoft and Biomedical Knowledge Base
Investigating biomarkers and drug targets from public data using QIAGEN Omicsoft Diseaseland and QIAGEN Ingenuity Pathway Analysis (IPA)
180 views
In this 90-minute webinar, we’ll cover how to easily query non-oncology public data (GEO, SRA and more) to:
• Rapidly query and identify public datasets that fit our search criteria
• Discover and validate biomarker expression in disease tissue, different treatments and response groups
• Identify a list of biomarkers specific to a condition (non-responders, disease-specific, cell-type specific and more)
• Confirm condition-specific biomarkers through gene expression heatmaps
• Investigate biological mechanisms through network study
• Rapidly query and identify public datasets that fit our search criteria
• Discover and validate biomarker expression in disease tissue, different treatments and response groups
• Identify a list of biomarkers specific to a condition (non-responders, disease-specific, cell-type specific and more)
• Confirm condition-specific biomarkers through gene expression heatmaps
• Investigate biological mechanisms through network study
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Biomarker discovery, target validation, and variant identification using QIAGEN OmicSoft...
In this webinar, users will learn how to leverage solutions from QIAGEN...
QIAGEN OmicSoft and Biomedical Knowledge Base
Target exploration and cell line selection for drug discovery
Cancer cell line models have been a cornerstone of cancer research for...
QIAGEN OmicSoft and Biomedical Knowledge Base
Mining curated knowledge graphs and validating with experimental datasets to accelerate your drug...
In an era of near-limitless public experimental data but little...
QIAGEN OmicSoft and Biomedical Knowledge Base
Exploring pan-cancer immunomodulators for biomarker discovery and validation using TCGA and...
Cancer outcome is influenced by both the tumor microenvironment and host...